Burcon NutraScience Corporation (BUR)
Create an AlertBUR Key Stats
| Income Statement | |
| Revenue TTM | 0.0069M |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.1742 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -5.238M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -25682% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 80.01M |
| Enterprise Value | 72.13M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 7.198 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -1.103M |
| Return on Equity | -56.46% |
BUR News
- Burcon Sets Fourth Quarter and Fiscal Year 2013 Conference Call for June 25, 201... Jun 18
- Burcon Advances Commercial Roll-Out of Peazazz Pea Protein by Signing MTAs With ... Jun 13
- Burcon to Showcase Peazazz Pea Protein at the 2013 Institute of Food Technologis... Jun 5
- Burcon NutraScience to Present at B. Riley's 14th Investor Conference on May 20,... May 9
- Burcon Sees CLARISOY Commercialization Ramping up in 2013 GlobeNewswire Apr 24
- Stocks Hitting 52-Week Lows Benzinga Apr 16
- Burcon Awarded Third U.S. CLARISOY Patent in Two Months GlobeNewswire Apr 11
- BURCON NUTRASCIENCE ENGAGES LIOLIOS GROUP TO LEAD NEW INVESTOR RELATIONS PROGRAM noodls Apr 8
- Burcon Granted Second U.S. CLARISOY Patent GlobeNewswire Apr 4
- Stocks Hitting 52-Week Lows Benzinga Feb 27
BUR Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Burcon NutraScience Corporation is down 59.52% over the last year vs S&P 500 Total Return up 23.89%, ARCA biopharma down 57.69%, and Advanced Proteome Therpt up 146.7%.
BUR Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these BUR related companies
Pro Ratings for BUR
Pro Strategies Featuring BUR
Did Burcon NutraScience Corporation make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
BUR Profile
Sector: Healthcare
Industry: Biotechnology
Other BUR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BUR | 2.53 | -0.22 | -8.00% | 80.01M |
